Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients

被引:23
|
作者
London, Frederic [1 ]
El Sankari, Souraya [1 ]
van Pesch, Vincent [1 ]
机构
[1] Clin Univ St Luc, Dept Neurol, 10 Ave Hippocrate, B-1200 Brussels, Belgium
关键词
Multiple sclerosis; Multimodal evoked potentials; Predictive value; EDSS; Disability; PREDICT; PROGRESSION; ABNORMALITIES; DIAGNOSIS; MARKERS; MRI;
D O I
10.1016/j.clinph.2016.12.029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The aim of this study was to investigate whether early alterations in evoked potentials (EPs) have a prognostic value in relapsing-remitting multiple sclerosis (RRMS). Methods: We retrospectively selected 108 early MS patients with a neurological follow-up ranging from 5 to 15 years, in whom multimodal EPs (visual, brainstem auditory, somatosensory and motor) were performed at diagnosis. A conventional ordinal score was used to quantify the observed abnormalities. Results: The extent of change in the composite EP score was well correlated to the Expanded Disability Status Scale (EDSS) at ten years (Y-10) and up to 15 years (Y11-15) after disease onset. Analysis of the predictive value of the EP score showed an increased risk of disability progression at Y-10 and Y11-15 of 60% (p < 0.0001) and 73% (p < 0.0001) respectively in patients with an EP score > 4. Conversely, the risk of disability progression at Y-10 and Y11-15 associated with a lower EP score (64) was reduced to 16% and 20% respectively. Conclusions: Our data support the good predictive value for long-term disability progression of multimodal EPs performed early after disease onset in RRMS patients. Significance: This study, performed in a homogeneous RRMS cohort with long term follow-up, demonstrates the value of an early comprehensive neurophysiological assessment as a marker for future disability. (C) 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 50 条
  • [1] Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients
    London, F.
    El Sankari, S.
    van Pesch, V.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 133 - 133
  • [2] Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis
    Jung, P.
    Beyerle, A.
    Ziemann, U.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 (04): : 553 - 556
  • [3] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    [J]. NEUROLOGY, 2020, 94 (15)
  • [4] Relation between acute exacerbations and long-term disability in patients with relapsing-remitting multiple sclerosis
    Gaillard, N
    Fabrot-Perray, R
    Lebayon, A
    Castelnovo, G
    Labauge, P
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S111 - S111
  • [5] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [6] Multimodal (visual, motor, and somatosensory) evoked potentials as markers of clinical disability in relapsing-remitting and secondary progressive multiple sclerosis
    Schlaeger, RMM
    Schindler, C
    Grize, L
    Kappos, L
    Fuhr, P
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 13 - 13
  • [7] Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis - A systematic review
    Langer-Gould, Annette
    Popat, Rita A.
    Huang, Stella M.
    Cobb, Kristin
    Fontoura, Paulo
    Gould, Michael K.
    Nelson, Lorene M.
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (12) : 1686 - 1691
  • [8] Early prediction of the long-term response to interferon beta in relapsing-remitting multiple sclerosis patients
    Schmit, E.
    Gourraud, P. A.
    Couturier, N.
    Le Page, E.
    Vukusic, S.
    Debouverie, M.
    Defer, G. L.
    Lebrun, C.
    Frangoulis, B.
    Achiti, J.
    Merle, H.
    Edan, G.
    Fontaine, B.
    Clanet, M.
    Brassat, D.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S58 - S59
  • [9] Long-term outcome of minocycline in relapsing-remitting multiple sclerosis
    Zhang, Y.
    Metz, L. M.
    Yong, V. W.
    Bell, R. B.
    Yeung, M.
    Patry, D.
    Mitchel, J. R.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 (09): : 1226 - 1226
  • [10] Early abnormalities of evoked potentials predict long-term disability in patients with multiple sclerosis
    Kallmann, B
    Büttner, S
    Toyka, K
    Reiners, K
    Rieckmann, R
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 118 - 118